BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37437937)

  • 1. Analysis of Correlation between Bone Marrow Vascular Endothelial Growth Factor per Platelet Count and Blast Percentage in Hematologic Malignancies.
    Cho CH
    Ann Clin Lab Sci; 2023 May; 53(3):469-475. PubMed ID: 37437937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of neutrophil gelatinase-associated lipocalin, vascular endothelial growth factor, and soluble receptor for advanced glycation end-products in bone marrow supernatant in hematologic malignancies.
    Cho CH; Cha J
    Clin Biochem; 2020 Jun; 80():19-24. PubMed ID: 32304694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of bone marrow supernatant neutrophil gelatinase-associated lipocalin and hematological parameters in hematological malignancy.
    Cho CH; Cha J; Chang EA; Nam MH; Park SJ; Sung HJ; Lee SR
    J Clin Lab Anal; 2020 Jun; 34(6):e23253. PubMed ID: 32091174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of Luminex and Enzyme-Linked Immunosorbent Assay Measuring Vascular Endothelial Growth Factor and Six Cytokines Quantitatively in Bone Marrow Aspiration Supernatant: Pilot Study.
    Cho CH; Park MC
    Ann Clin Lab Sci; 2022 Jul; 52(4):663-676. PubMed ID: 36197768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of peripheral blood neutrophil gelatinase-associated lipocalin levels with bone marrow neutrophil gelatinase-associated lipocalin levels and neutrophil count in hematologic malignancy.
    Cho CH; Yoon J; Kim DS; Kim SJ; Sung HJ; Lee SR
    J Clin Lab Anal; 2019 Jul; 33(6):e22920. PubMed ID: 31090234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies.
    Yang CF; Gau JP; Hsiao LT; Hsu CY
    Pathology; 2021 Oct; 53(6):740-745. PubMed ID: 33745704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.
    Drexler B; Tzankov A; Martinez M; Baerlocher S; Passweg JR; Dirnhofer S; Tsakiris DA; Dirks J
    Int J Lab Hematol; 2021 Oct; 43(5):1078-1084. PubMed ID: 33709561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia.
    Brunner B; Gunsilius E; Schumacher P; Zwierzina H; Gastl G; Stauder R
    J Hematother Stem Cell Res; 2002 Feb; 11(1):119-25. PubMed ID: 11847008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow vascular endothelial growth factor level per platelet count might be a significant predictor for the treatment outcomes of patients with diffuse large B-cell lymphomas.
    Kim JS; Gang GW; Lee SR; Sung HJ; Park Y; Kim DS; Choi CW; Kim BS
    Jpn J Clin Oncol; 2015 Oct; 45(10):914-20. PubMed ID: 26185139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
    Verstovsek S; Estey E; Manshouri T; Giles FJ; Cortes J; Beran M; Rogers A; Keating M; Kantarjian H; Albitar M
    Br J Haematol; 2002 Jul; 118(1):151-6. PubMed ID: 12100142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
    Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the Relationship between the Expression Levels of Neutrophil Gelatinase-Associated Lipocalin and Cytokine Genes in Bone Marrow.
    Mun S; Park MC; Cho CH
    Int J Med Sci; 2021; 18(14):3290-3298. PubMed ID: 34400898
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.
    Amin HM; Yang Y; Shen Y; Estey EH; Giles FJ; Pierce SA; Kantarjian HM; O'Brien SM; Jilani I; Albitar M
    Leukemia; 2005 Sep; 19(9):1567-72. PubMed ID: 16049515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiogenesis in patients with hematologic malignancies].
    Mesters RM; PadrĂ³ T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
    Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias.
    Dunphy CH; O'Malley DP; Perkins SL; Chang CC
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):154-9. PubMed ID: 17525626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction.
    Tuzuner N; Cox C; Rowe JM; Bennett JM
    Leuk Res; 1994 Aug; 18(8):559-64. PubMed ID: 8065157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
    Zou WR; Liu T; Meng WT; Yu J; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.